Boryung Pharm (003850) - Total Liabilities

Latest as of September 2025: ₩537.67 Billion KRW ≈ $364.37 Million USD

Based on the latest financial reports, Boryung Pharm (003850) has total liabilities worth ₩537.67 Billion KRW (≈ $364.37 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 003850 cash flow conversion to assess how effectively this company generates cash.

Boryung Pharm - Total Liabilities Trend (2009–2024)

This chart illustrates how Boryung Pharm's total liabilities have evolved over time, based on quarterly financial data. Check 003850 financial resilience to evaluate the company's liquid asset resilience ratio.

Boryung Pharm Competitors by Total Liabilities

The table below lists competitors of Boryung Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Ari Real Estate Arena Investment Ltd TA:ARIN	Israel	ILA1.60 Billion
Worldline SA PA:WLN	France	€9.10 Billion
VersaBank TO:VBNK	Canada	CA$5.60 Billion
Hovnanian Enterprises Inc NYSE:HOV	USA	$1.90 Billion
Ningbo Lehui International Engineering Equipment Co Ltd Class A SHG:603076	China	CN¥2.25 Billion
Shenzhen Silver Basis Technology Co Ltd SHE:002786	China	CN¥3.44 Billion
GuangDong GenSho Logistics Co SHG:603813	China	CN¥813.54 Million
Zhejiang Extek Technology Co. Ltd. A SHE:301399	China	CN¥188.59 Million

Liability Composition Analysis (2009–2024)

This chart breaks down Boryung Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 003850 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.39	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Boryung Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Boryung Pharm (2009–2024)

The table below shows the annual total liabilities of Boryung Pharm from 2009 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩379.58 Billion ≈ $257.24 Million	+3.64%
2023-12-31	₩366.26 Billion ≈ $248.21 Million	-2.58%
2022-12-31	₩375.97 Billion ≈ $254.79 Million	+6.11%
2021-12-31	₩354.33 Billion ≈ $240.12 Million	+15.15%
2020-12-31	₩307.71 Billion ≈ $208.53 Million	+36.96%
2019-12-31	₩224.68 Billion ≈ $152.26 Million	+15.86%
2018-12-31	₩193.91 Billion ≈ $131.41 Million	+26.86%
2017-12-31	₩152.86 Billion ≈ $103.59 Million	-24.53%
2016-12-31	₩202.55 Billion ≈ $137.27 Million	+59.22%
2012-12-31	₩127.21 Billion ≈ $86.21 Million	+2.25%
2011-12-31	₩124.42 Billion ≈ $84.32 Million	+13.68%
2010-12-31	₩109.45 Billion ≈ $74.17 Million	+107.40%
2009-12-31	₩52.77 Billion ≈ $35.76 Million	--

About Boryung Pharm

KO:003850 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$569.08 Million

₩839.74 Billion KRW

Market Cap Rank

#11865 Global

#371 in Korea

Share Price

₩9940.00

Change (1 day)

-1.39%

52-Week Range

₩8170.00 - ₩10680.00

All Time High

₩21257.60